Strides Pharma Science Ltd.

STAR

₹836.55

-4.3% (-37.55)

Market Cap

₹7,714 Cr.

P/E

21.25

Key Ratios

Edit Ratio's

Market cap

7,714 Cr

21.25

Prom Holding

28.30 %

ROE (%)

140

ROCE (%)

20.99

Div Yield (%)

0.78

Sales

4,664 Cr

OPM (%)

18.91 %

Debt to Equity

0.70

Edit Ratio's

About

Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headqu… Read more

Low

513

52W Range

High

1675

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Pledge

Promoters have pledged a significant portion of their holding
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Balance Sheet Strength

Balance sheet of the company is moderately strong
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

50 %

(as of Mar 19)

Historic

Acarbose - Market Share

21 %

(as of Mar 19)

Historic

Acetazolamide - Market Share

11 %

(as of Mar 19)

Historic

Amlodipine - Market Share

18 %

(as of Mar 19)

Historic

Benzonatate - Market Share

52 %

(as of Mar 19)

Historic

Buspirone - Market Share

36 %

(as of Mar 19)

Historic

Calcitriol SGC - Market Share

20 %

(as of Mar 19)

Historic

Efavirenz - Market Share

27 %

(as of Mar 19)

Historic

Ibuprofen Rx - Market Share

23 %

(as of Mar 19)

Historic

Ketoconazole - Market Share

63 %

(as of Mar 19)

Source/Historic

Methoxsalen - Market Share

65 %

(as of Mar 19)

Historic

Ranitidine - Market Share

53 %

(as of Mar 19)

Historic

Vanco Caps - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Operating Profit Break-Up

Asset Break-Up - Segment Wise

Asset Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Pediacare

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Laurus Labs Ltd.
HLE Glascoat Ltd.
IOL Chemicals And Pharmaceuticals Ltd.

FAQs on Strides Pharma Science Ltd. Business

What does Strides Pharma Scien do?

Strides Pharma Science Limited is a global pharmaceutical company established in 1990, with headquarters in Bangalore, India. It operates in Regulated Markets and Emerging Markets, with a strong R&D facility and presence in 100 countries.

Who are the competitors of Strides Pharma Scien?

Strides Pharma Scien major competitors are FDC, Marksans Pharma, Procter&Gamble Healt, Unichem Lab, Sequent Scientific, Guj. Themis Biosyn, Orchid Pharma.
Market Cap of Strides Pharma Scien is ₹7,714 Crs.
While the median market cap of its peers are ₹4,284 Crs.

Is Strides Pharma Scien financially stable compared to its competitors?

Strides Pharma Scien seems to be less financially stable compared to its competitors.
Altman Z score of Strides Pharma Scien is 3.23 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Jul	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Dec	Jun Dec		Mar Jun	Mar Jun Sep Dec	Mar
Investor Presentation	May Jul	Feb Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Dec		Mar	Jun Sep Dec	Jun Sep Dec		Mar Dec	Jun Sep
Conference Call	Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Jun Sep Dec	Sep Dec		Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Strides Pharma Science Ltd.

View the discussion on ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Strides Pharma Science Ltd.

Strides Pharma Science Ltd.

Key Ratios

About

Timeline

Company Timeline

7 Yes

2 Neutral

8 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Revenue Recognition

Promoter Holding

Depreciation Effect

Pledge

Retail Holding

Price & Performance

Capex vs ROCE

ROE

Working Capital

Current vs Historic Valuation

Balance Sheet Strength

Debt

Share price

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Customer Segment

UNLOCK PREMIUM

Operating Profit Break-Up

UNLOCK PREMIUM

Asset Break-Up - Segment Wise

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

What does Strides Pharma Scien do?

Who are the competitors of Strides Pharma Scien?

Is Strides Pharma Scien financially stable compared to its competitors?

SIGN UP FOR FREE